The Supply Chain Matters blog highlights and comments on the FDA’s New Era of Smarter Food Safety Low or No Cost Traceability Challenge, demonstrating cost effective means to support end-to-end supply chain item level traceability.
The Supply Chain Matters blog highlights the Biden Administration plans to invest $2.7 billion into domestic supply network capabilities of essential vaccine components
The Supply Chain Matters blog highlights how current and future COVID-19 vaccine supply has drawn active supply chain resiliency actions. In an example is Moderna’s announced deal with Canada to build and operate a domestic MRNA vaccine production facility in that country.
This Supply Chain Matters editorial commentary provides highlights of added developments specifically related to U.S. supplies of medical PPE and how government and private industry actions still appear not to be aligned.
The Supply Chain Matters blog provides a look back and current viewpoint of efforts to encourage a U.S. domestic production capability of medical PPE. Based on one domestic supplier’s perspective, optimism still prevails especially around more educated and more risk aware healthcare procurement teams
The Supply Chain Matters blog provides an updated capsule of noteworthy updates to prior global supply chain news developments that we have previously highlighted for our readers. In this update, we update developments related to the distribution of the Johnson and Johnson COVID-19 vaccine, and in Airbus efforts to renew monthly manufacturing volumes.
The Supply Chain Matters blog provides a capsule of noteworthy updates to prior global supply chain news developments. Included companies and developments in this update are Johnson and Johnson, Canadian National and Kansas City Southern Railroad, railroad, Blue Yonder and Kinaxis, and the initial legal trade disputes related to the USMCA trade agreement.
In this Supply Chain Matters COVID-19 Healthcare Delivery Supply Chain News Capsule we highlight the latest developments related to global availability of COVID-19 vaccine supply, along with the reported existence of counterfeit vaccine supplies.
The Johnson & Johnson Vaccine Production Mix-up- The Message of Stepped-Up Quality Monitoring and Controls
The Supply Chain Matters blog provides commentary on last week’s revelation of a COVID-19 vaccine production facility’s snafu in producing the Johnson & Johnson vaccine. The commentary addresses what mitigation actions the industry needs to undertake to insure the quality needs of COVID-19 vaccines produced at such volumes.
The Supply Chain Matters blog features our annual listing of our most read blog commentaries that were created and published during the year 2020. In this Part Two posting, we highlight in descending order from Number 14 to Number 1 ranked blog content.
The Supply Chain Matters blog features our annual listing of our most read blog commentaries that were created and published during the year 2020. In this Part One posting, we highlight in descending order from Number 25 to Number 15 ranked blog content.
The Supply Chain Matters blog highlights an Avery Dennison announcement of a connected product Cloud, ushering in new capabilities of more highly connected products.